Kennedy Giulia C's Form 4 filing
Veracyte, Inc. (VCYT) · filed Sep 9, 2021
- Accession no.
- 0001384101-21-000155
- Filed
- Sep 9, 2021
- Trade date
- Sep 7-8, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $680.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kennedy Giulia CCIK 0001769333 | Officer (Chief Scientific & Med Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 7, 2021 | Common Stock | MOption exerciseAcquired | +4,406 | $5.98 | +$26,347.88 | 55,381 | Direct | |
| Sep 7, 2021 | Common Stock | MOption exerciseAcquired | +3,750 | $20.21 | +$75,787.5 | 59,131 | Direct | |
| Sep 7, 2021 | Common Stock | MOption exerciseAcquired | +4,375 | $24.69 | +$108,018.75 | 63,506 | Direct | |
| Sep 7, 2021 | Common Stock | SSaleDisposed | −12,034 | $50.52F2 | −$607,957.68 | 51,472 | Direct | |
| Sep 7, 2021 | Common Stock | SSaleDisposed | −497 | $51.23F3 | −$25,461.31 | 50,975 | Direct | |
| Sep 8, 2021 | Common Stock | SSaleDisposed | −926 | $50.53 | −$46,790.78 | 50,049 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 7, 2021 | Common Stock | MOption exerciseDisposed | −4,406 | $0.00 | $0 | 8,813 | Direct | |
| Sep 7, 2021 | Common Stock | MOption exerciseDisposed | −3,750 | $0.00 | $0 | 22,500 | Direct | |
| Sep 7, 2021 | Common Stock | MOption exerciseDisposed | −4,375 | $0.00 | $0 | 43,750 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents weighted average sales price. Sale prices for the transactions range from $50.06 to $51.06. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Referenced by the price of 1 transaction in Table I.
- F3
Represents weighted average sales price. Sale prices for the transactions range from $51.07 to $51.33. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Referenced by the price of 1 transaction in Table I.